{
    "Trade/Device Name(s)": [
        "RapidOne-Cocaine-150 Test",
        "RapidOne-Cocaine-150 Test",
        "RapidOne-Cocaine Test"
    ],
    "Submitter Information": "American BioMedica Corporation",
    "510(k) Number": "K053422",
    "Predicate Device Reference 510(k) Number(s)": [
        "K990822"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO"
    ],
    "Summary Letter Date": "June 15, 2006",
    "Summary Letter Received Date": "June 7, 2006",
    "Submission Date": "December 2, 2005",
    "Regulation Number(s)": [
        "21CFR862.3250"
    ],
    "Regulation Name(s)": [
        "Cocaine & cocaine metabolite test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzoyl ecgonine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Competitive immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for RapidOne-Cocaine-150 Test, a lateral flow immunoassay for qualitative detection of benzoyl ecgonine in urine.",
    "Indications for Use Summary": "Qualitative screening of benzoyl ecgonine in human urine; provides preliminary results for determining need for confirmatory GC/MS testing; intended for professional use only.",
    "fda_folder": "Toxicology"
}